Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review-Reference-Cited by-同舟云学术

Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review

Published:2010-09-14 Issue:2 Volume:40 Page:117-134
ISSN:1080-0549
Container-title:Clinical Reviews in Allergy & Immunology
language:en
Short-container-title:Clinic Rev Allerg Immunol

Author:

Borchers Andrea T.,Chang Christopher,Keen Carl L.,Gershwin M. Eric

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s12016-010-8211-5.pdf

Reference148 articles.

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304

2. Bradley B, Branley HM, Egan JJ et al (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63(Suppl 5):v1–v58

3. 2Travis WD, Hunninghake G, King TE Jr et al (2008) Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177:1338–1347

4. Society AT (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646–664

5. Roggli VL, Gibbs AR, Attanoos R et al (2010) Pathology of asbestosis—an update of the diagnostic criteria: report of the Asbestosis Committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med 134:462–480

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-02

2. Clinical features analysis and treatment of systemic lupus erythematosus related interstitial lung disease;International Journal of Rheumatic Diseases;2024-06

3. Interstitial lung diseases: never forget to think about it in primary care;Expert Review of Respiratory Medicine;2024-02

4. Gastroesophageal reflux disease and idiopathic pulmonary fibrosis risk: A mendelian randomization study;European Journal of Inflammation;2024-01

5. Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis;Cellular and Molecular Biology;2023-11-15